Ticker
CLDI
Asset Class
Health Care
Assets Under Management
23.45M
Holdings
10+
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.
Loading chart…